HMGN OTC
Hemagen Diagnostics, Inc.
1W: +0.0%
1M: +0.0%
3M: -92.3%
YTD: +0.0%
1Y: +100.0%
3Y: +100.0%
5Y: -97.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$4M
-21.4% ▼
5Y CAGR: -2.1%
Gross Profit
$2M
-17.7% ▼
5Y CAGR: -3.0%
Operating Income
-$438K
+7.4% ▲
Net Income
-$907K
-3.0% ▼
EPS (Diluted)
$-0.06
+2.5% ▲
EBITDA
-$274K
+3.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $6M | $5M | $5M | $5M | $4M |
| YoY Growth | +42.1% | -15.0% | -3.7% | -1.5% | -21.4% |
| Cost of Revenue | $4M | $3M | $3M | $3M | $2M |
| Gross Profit | $3M | $2M | $2M | $2M | $2M |
| Gross Margin | 43.5% | 38.2% | 45.1% | 38.1% | 39.9% |
| R&D Expenses | $147K | $92K | $25K | $5K | $45K |
| SG&A Expenses | $3M | $2M | $2M | $2M | $2M |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M |
| Operating Income | $118K | -$349K | $236K | -$473K | -$438K |
| Operating Margin | 1.9% | -6.4% | 4.5% | -9.2% | -10.8% |
| Interest Expense | $376K | $404K | $332K | $407K | $469K |
| Income Before Tax | -$244K | -$709K | -$67K | -$876K | -$907K |
| Tax Expense | $129K | $21K | $90K | $4K | $0 |
| Net Income | $427K | -$808K | -$156K | -$880K | -$907K |
| Net Margin | 6.7% | -14.9% | -3.0% | -17.1% | -22.4% |
| EPS (Diluted) | $0.03 | $-0.05 | $-0.01 | $-0.06 | $-0.06 |
| EBITDA | $226K | -$192K | $429K | -$284K | -$274K |
| Shares Outstanding | 15M | 15M | 15M | 15M | 15M |